Brief: Spectral Medical announces FDA approval to add up to 10 additional tigris clinical trial sites
18/08/2022 13:18
Aug 18 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL ANNOUNCES FDA APPROVAL TO ADD UP TO 10 ADDITIONAL
TIGRIS CLINICAL TRIAL SITES
Source text for Eikon: ID:nGNX8MBfkt
Further company coverage: EDT.TO
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%